Verano Holdings (VRNO) Enterprise Value (2021 - 2026)
Verano Holdings' (VRNO) quarterly Enterprise Value came in at -$75.8 million in Q1 2026, up 11.85% year-on-year from -$67.8 million in Q1 2025, and up 10.29% on a QoQ basis from -$84.5 million in Q4 2025.
Verano Holdings (VRNO) Enterprise Value (2021 - 2026) Analysis & Trends
Verano Holdings (VRNO) has 6 years of Enterprise Value data on file, last reported at -$75.8 million in Q1 2026.
- On a quarterly basis, Enterprise Value rose 11.85% year-over-year to -$75.8 million in Q1 2026; TTM through Mar 2026 was -$75.8 million, a 11.85% increase from a year earlier, with the FY2025 full-year figure at -$84.5 million, up 5.22% from the prior year.
- Enterprise Value for Q1 2026 stood at -$75.8 million, up from -$84.5 million in the prior quarter.
- Over the last five years, Enterprise Value for VRNO reached as high as -$65.2 million in Q3 2024 and fell as low as -$193.8 million in Q1 2024.
- Historically, Enterprise Value has averaged -$102.2 million across 5 years, with a median of -$87.6 million in 2024.
- Across the five-year window, Enterprise Value plunged 105.96% in 2023 and jumped 55.63% in 2025, its largest moves.
- Year by year, Enterprise Value stood at -$84.9 million in 2022, then plunged by 105.96% to -$174.8 million in 2023, then jumped by 48.99% to -$89.2 million in 2024, then gained by 5.22% to -$84.5 million in 2025, then rose by 10.29% to -$75.8 million in 2026.
- Per Business Quant data, the three most recent Enterprise Value figures were -$75.8 million in Q1 2026, -$84.5 million in Q4 2025, and -$84.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | -1.86 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -3.74 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -1.94 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -4.05 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -2.15 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | -33.59 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -1.80 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -1.32 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -428.00 Mn |
| 10 | Verano Holdings | 2.02 Bn | 1.94 Bn | 98.98 Mn | -75.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -75.80 Mn |
| Dec 31, 2025 | -84.50 Mn |
| Sep 30, 2025 | -84.40 Mn |
| Jun 30, 2025 | -70.35 Mn |
| Mar 31, 2025 | -86.00 Mn |
| Dec 31, 2024 | -89.15 Mn |
| Sep 30, 2024 | -65.21 Mn |
| Jun 30, 2024 | -130.05 Mn |
| Mar 31, 2024 | -193.80 Mn |
| Dec 31, 2023 | -174.76 Mn |
| Sep 30, 2023 | -129.84 Mn |
| Jun 30, 2023 | -102.58 Mn |
| Mar 31, 2023 | -95.13 Mn |
| Dec 31, 2022 | -84.85 Mn |
| Sep 30, 2022 | -76.42 Mn |
| Jun 30, 2022 | -92.83 Mn |
| Dec 31, 2021 | -97.84 Mn |